Anabolic therapy of osteoporosis

被引：2
|
作者：
Fernández-García, DF [1 ]
Alonso, G [1 ]
Muñoz-Torres, M [1 ]
机构：
[1] Hosp Univ San Cecilio, Unidad Metab Oseo, Serv Endocrinol & Nutr, Granada, Spain
来源：
MEDICINA CLINICA | 2005年 / 125卷 / 09期
关键词：
osteoporosis; anabolic therapies; strontium; parathyroid hormone;
D O I：
10.1157/13078782
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pharmacological treatment of osteoporosis is based mainly on antiresorptive agents. However, there have been recently developed a group of drugs whose mechanism of action is the direct stimulation of bone formation: these drugs are named bone anabolic therapies. Among these compounds are fluoride, growth hormone (GH), insulin-like growth factor type I (IGF-I) and statins. Two further agents with major evidences of efficacy include strontium ranelate and parathyroid hormone (PTH) and its fragments. The present work reviews the current evidences of anabolic agents used in the treatment of osteoporosis.
引用
收藏
页码：341 / 345
页数：5
相关论文
共 50 条
  • [21] Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches
    Cosman, Felicia
    CURRENT OSTEOPOROSIS REPORTS, 2014, 12 (04) : 385 - 395
  • [22] Clinical perspectives: Use of anabolic therapy in the management of osteoporosis
    Bilezikian, J. P.
    Silverman, S.
    Heaney, R.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S361 - S361
  • [23] Optimizing Sequential and Combined Anabolic and Antiresorptive Osteoporosis Therapy
    Leder, Benjamin Z.
    JBMR PLUS, 2018, 2 (02) : 62 - 68
  • [24] Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches
    Felicia Cosman
    Current Osteoporosis Reports, 2014, 12 : 385 - 395
  • [25] Anabolic Therapy with Osteoporosis: New Aspects and Insights - Dennis Black
    不详
    JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (02): : 113 - 113
  • [26] ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS
    Mechanick, Jeffrey I.
    Hurley, Daniel L.
    Garvey, W. Timothy
    ENDOCRINE PRACTICE, 2017, 23 (06) : 749 - 750
  • [27] ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS
    Bhadada, S. K.
    Gopalaswamy, V.
    Dhibar, D. P.
    Gupta, V.
    Khandelwal, N.
    Bhansali, A.
    Garg, S.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S761 - S761
  • [28] Clinical review 123:: Hot topic -: Anabolic therapy for osteoporosis
    Rosen, CJ
    Bilezikian, JP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03): : 957 - 964
  • [29] Anabolic therapy in primary osteoporosis: What does the future hold?
    Licata A.A.
    Clinical Reviews in Bone and Mineral Metabolism, 2006, 4 (4): : 305 - 316
  • [30] Anabolic agents for osteoporosis
    Lindsay, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (05) : 940 - 940
12345